|
|
41
|
|
|
B4612
|
|
|
XIGDUO 5MG|1G TAB (AZN) DAPAGLIFLOZIN|METFORMIN
|
|
|
DAPAGLIFLOZIN|METFORMIN
|
|
|
XIGDUO
|
|
|
30'S
|
|
|
B
|
|
|
39.36
|
|
|
1.312
|
|
|
5MG|1G
|
|
|
TAB
|
|
|
30
|
|
|
BOX
|
|
|
AZN
|
|
|
ASTRAZENECA AB
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2024-08-16
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
2024-08-16
|